Common Contracts
3 similar Lease Termination Agreement contracts by Myriad Genetics Inc
LEASE TERMINATION AGREEMENT (Myriad Genetics: Phase I)Lease Termination Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
THIS LEASE TERMINATION AGREEMENT (this “Agreement”) is entered into as of the 18th day of December, 2023 (the “Effective Date”) by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”) and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”) (each a “Party” and collectively the “Parties”), with reference to the following recitals:
LEASE TERMINATION AGREEMENT (Myriad Genetics: Phase III)Lease Termination Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
THIS LEASE TERMINATION AGREEMENT (this “Agreement”) is entered into as of the 18th day of December, 2023 (the “Effective Date”) by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”) and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”) (each a “Party” and collectively the “Parties”), with reference to the following recitals:
LEASE TERMINATION AGREEMENT (Myriad Genetics: Phase II)Lease Termination Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
THIS LEASE TERMINATION AGREEMENT (this “Agreement”) is entered into as of the 18th day of December, 2023 (the “Effective Date”) by and between HCPI/UTAH II, LLC, a Delaware limited liability company (“Landlord”) and MYRIAD GENETICS, INC., a Delaware corporation (“Tenant”) (each a “Party” and collectively the “Parties”), with reference to the following recitals:
